July 07, 2023
Hills et al v. BioXcel Therapeutics, Inc. et al
Case Number:
3:23-cv-00915
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Grant & Eisenhofer
- Hurwitz Sagarin
- Izard Kindall
- Jacobs & Dow
- Labaton Keller
- Latham & Watkins
- Levi & Korsinsky
- Lowenstein Sandler
- Ment Law Group
- Mott Zezula
- Zeisler & Zeisler
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
May 28, 2025
Class Suit Against AI Drugmaker Back On After Mediation Fails
After the parties failed to settle through mediation, a Connecticut federal judge has unpaused the latest iteration of a proposed class action accusing artificial intelligence-driven drugmaker BioXcel Therapeutics Inc. of false and misleading statements about U.S. Food and Drug Administration compliance issues surrounding a dementia drug.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login